ArticleThe oncologist2026
Invasive lobular breast carcinoma with diffuse gastrointestinal metastases: a visual diagnostic pitfall.
Article in The oncologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive lobular carcinoma (ILC) of the breast demonstrates a distinct infiltrative growth pattern and a predilection for metastasis to the gastrointestinal tract, often without forming discrete masses. We report on a 64-year-old woman with a history of estrogen receptor-positive, human epidermal growth factor receptor 2-negative ILC who presented with progressive nausea, vomiting, and diarrhea. Recent surveillance imaging had shown no evidence of metastatic disease. Computed tomography revealed nonspecific findings despite extensive mucosal involvement that was later identified on endoscopy. Upper endoscopy and colonoscopy demonstrated diffuse nodular and congested mucosa throughout the duodenum and colon without focal lesions. Histologic evaluation revealed poorly cohesive tumor cells infiltrating the lamina propria, and immunohistochemistry was positive for cytokeratin 7, GATA3, and estrogen receptor, confirming metastatic breast carcinoma. Diffuse gastrointestinal involvement by ILC is uncommon and may mimic inflammatory, infectious, ischemic, or medication-related conditions, contributing to delayed diagnosis. This case highlights an important diagnostic pitfall and underscores the need to consider metastatic disease in patients with a history of lobular breast carcinoma who present with unexplained gastrointestinal symptoms, even in the absence of radiographically apparent disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.